17β-estradiol reduces stroke injury in estrogen-deficient female animals

被引:260
作者
Rusa, R
Alkayed, NJ
Crain, BJ
Traystman, RJ
Kimes, AS
London, ED
Klaus, JA
Hurn, PD
机构
[1] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[3] NIDA, Baltimore, MD 21224 USA
关键词
cerebral blood flow; cerebral ischemia; 17; beta-estradiol; estrogen replacement therapy; stroke; rats;
D O I
10.1161/01.STR.30.8.1665
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The importance of postmenopausal estrogen replacement therapy for stroke in females remains controversial. We previously showed that female rats sustain less infarction in reversible middle cerebral artery occlusion (MCAO) than their ovariectomized counterparts and that vascular mechanisms are partly responsible for improved tissue outcomes. Furthermore, exogenous estrogen strongly protects the male brain, even when administered in a single injection before MCAO injection. The present study examined the hypothesis that replacement of 17 beta-estradiol to physiological levels improves stroke outcome in ovariectomized, estrogen-deficient female rats, acting through blood flow-mediated mechanisms. Methods-Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 25, or 100 mu g of 17 beta-estradiol administered through a subcutaneous implant or with a single Premarin (USP) injection(1 mg/kg) given immediately before ischemia was induced (n = 10 per group). Each animal subsequently underwent 2 hours of MCAO by the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored by laser-Doppler flowmetry throughout ischemia. Cortical and caudate-putamen infarction. volumes were determined by 2,3,5-triphenyltetrazolium chloride staining and digital image analysis. End-ischemic regional cerebral blood flow was measured in ovariectomized females with 0- or 25-mu g implants (n=4 per group) by C-14-iodoantipyrine quantitative autoradiography. Results-Plasma estradiol levels were 3.0+/-0.6, 20+/-8, and 46+/-10 pg/mL in the 0-, 25-, and 100-mu g groups, respectively. Caudate-putamen infarction (% of ipsilateral caudate-putamen) was reduced by long-term, 25-mu g estrogen treatment (13+/-4% versus 31+/-6% in the 0-mu g group, P<0.05, and 22+/-3% in the 100-mu g group). Similarly, cortical infarction (% of ipsilateral cortex) was reduced only in the 25-mu g group (3+/-2% versus 12+/-3% in the 0-mu g group, P<0.05, and 6+/-3% in the 100-mu g group. End-ischemic striatal or cortical blood flow was not altered by estrogen treatment at the neuroprotective dose. Infarction volume was unchanged by acute treatment before MCAO when estrogen-treated animals were compared with saline vehicle-treated animals. Conclusions-Long-term estradiol replacement within a low physiological range ameliorates ischemic brain injury in previously ovariectomized female rats. The neuroprotective mechanism is flow-independent, not through preservation of residual ischemic regional cerebral blood flow. Furthermore, the therapeutic range is narrow, because the benefit of estrogen in transient vascular occlusion is diminished at larger doses, which yield high, but still physiologically relevant, plasma 17 beta-estradiol levels. Lastly, unlike in the male brain, single-injection estrogen exposure does not salvage ischemic tissue in the female brain. Therefore, although exogenous steroid therapy protects both male and female estrogen-deficient brain, the mechanism may not be identical and depends on long-term hormone augmentation in the female.
引用
收藏
页码:1665 / 1669
页数:5
相关论文
共 39 条
  • [1] Gender-linked brain injury in experimental stroke
    Alkayed, NJ
    Harukuni, I
    Kimes, AS
    London, ED
    Traystman, RJ
    Hurn, PD
    [J]. STROKE, 1998, 29 (01) : 159 - 165
  • [2] Alkayed NJ, 1998, FASEB J, V12, pA954
  • [3] Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production
    Arnal, JF
    Clamens, S
    Pechet, C
    NegreSalvayre, A
    Allera, C
    Girolami, JP
    Salvayre, R
    Bayard, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 4108 - 4113
  • [4] Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats
    Bolego, C
    Cignarella, A
    Ruzza, R
    Zaarour, C
    Messi, E
    Zanisi, M
    Puglisi, L
    [J]. LIFE SCIENCES, 1997, 60 (25) : 2291 - 2302
  • [5] PLASMA CONCENTRATION OF LH, FSH, PROLACTIN, PROGESTERONE AND ESTRADIOL-17BETA THROUGHOUT 4-DAY ESTROUS-CYCLE OF RAT
    BUTCHER, RL
    COLLINS, WE
    FUGO, NW
    [J]. ENDOCRINOLOGY, 1974, 94 (06) : 1704 - 1708
  • [6] Estradiol protects against ischemic injury
    Dubal, DB
    Kashon, ML
    Pettigrew, LC
    Ren, JM
    Finklestein, SP
    Rau, SW
    Wise, PM
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (11) : 1253 - 1258
  • [7] Non-genomic effects of estrogen and the vessel wall
    Farhat, MY
    AbiYounes, S
    Ramwell, PW
    [J]. BIOCHEMICAL PHARMACOLOGY, 1996, 51 (05) : 571 - 576
  • [8] The vascular protective effects of estrogen
    Farhat, MY
    Lavigne, MC
    Ramwell, PW
    [J]. FASEB JOURNAL, 1996, 10 (05) : 615 - 624
  • [9] DECREASED RISK OF STROKE AMONG POSTMENOPAUSAL HORMONE USERS - RESULTS FROM A NATIONAL COHORT
    FINUCANE, FF
    MADANS, JH
    BUSH, TL
    WOLF, PH
    KLEINMAN, JC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (01) : 73 - 79
  • [10] Postmenopausal hormone therapy and mortality
    Grodstein, F
    Stampfer, MJ
    Colditz, GA
    Willett, WC
    Manson, JE
    Joffe, M
    Rosner, B
    Fuchs, C
    Hankinson, SE
    Hunter, DJ
    Hennekens, CH
    Speizer, FE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (25) : 1769 - 1775